Theleme Partners LLP Moderna, Inc. Call Options Transaction History

Theleme Partners LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $112,515 - $221,247	1,768 Added 28.5%	7,972 $532,000
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $145 Million - $239 Million	-1,433,796 Reduced 99.57%	6,204 $736,000
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $49 Million - $66.3 Million	-574,000 Reduced 28.5%	1,440,000 $153 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $140 Million - $210 Million	2,014,000 New	2,014,000 $200 Million
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $33.4 Million - $59.2 Million	282,000 New	282,000 $50.7 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Theleme Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Theleme Partners LLP with notifications on news.